- Metabolic Stability
- CYP Interaction
- Permeability & Transporters
- Physicochemical Properties
- Protein Binding
Discovery PK and Toxicology
Frontage’s formulation development and CTM manufacturing team designs formulations for targeted delivery of a therapeutic and then develops GMP manufacturing processes to ensure a high quality product is produced for clinical trials.
We develop finished products supporting IND, NDA filings and generic ANDA filings. Our facilities have been designed for flexibility, as we offer a variety of dosage forms and the ability to handle highly potent compounds and DEA-controlled substances.
FACT: We have worked with 400+ clients, supporting 400+ compounds and 700+ GMP batches.
[Webinar] Sterile Nanoemulsion Product Development: Challenges and Future Prospects: Hear a Frontage case study, learn about a nanoemulsion development process using a microfluidizer, and find out what factors to consider while developing a sterile ophthalmic nanoemulsion formulation.